Corteva

CTVA · NYSE · USD

$11.92−5.17%−$0.65

Close · October 2, 2026

At a glance

Revenue growth: +2.92%; 2025 vs 2024
Net income growth: +20.62%; 2025 vs 2024
Net margin: 6.3%; 2024: 5.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022
Total revenue	17,401	16,908	17,226	17,455
Cost of revenue	9,172	9,529	9,920	10,436
Gross profit	8,229	7,379	7,306	7,019
Selling, general and administrative	3,492	3,196	3,176	3,173
Research and development	1,474	1,402	1,337	1,216
Operating income	2,619	2,096	2,110	1,928
EBIT	1,868	1,508	1,326	1,505
EBITDA	3,071	2,735	2,537	2,728
Interest expense	180	233	233	79.0
Pre-tax income	1,688	1,275	1,093	1,426
Income tax	484	412	152	210
Net income	1,094	907	735	1,147
Net income to common shareholders	1,094	907	735	1,147
Basic EPS	1.60	1.31	1.04	1.59
Diluted EPS	1.60	1.30	1.03	1.58
Average shares (basic)	680	694	709	721
Average shares (diluted)	681	696	712	725